| Summary of the assets and liabilites measured at fair value on a recurring basis and their assigned levels within the hierarchy. |
| April 30, 2013 | | | | | | | | | | | | | | | | (in thousands) | | | | | Level 1 | | Level 2 | | Level 3 | | Other Assets Not Held at Fair Value | | Total | | | | | | | | | | | | | | | | | | | Financial assets: | | | | | | | | | | | | | | | | Cash equivalents | | | | $ | 10,222 | $ | 126,947 | $ | - | $ | - | $ | 137,169 | | Investments: | | | | | | | | | | | | | | | | Investment securities, trading – debt | | 37,846 | | 60,379 | | | - | | - | | 98,225 | | Investment securities, trading – equity | | 124,808 | | 61,988 | | | - | | - | | 186,796 | | Investment securities, available-for-sale | | 14,686 | | 5,084 | | - | | - | | 19,770 | | Investment in non-consolidated CLO | | | | | | | | | | | | | entity(1) | | - | | - | | - | | 314 | | 314 | | Investments in equity method investees(2) | | - | | - | | - | | 229,422 | | 229,422 | | Investments, other(3) | | - | | 61 | | - | | 7,470 | | 7,531 | | Derivative instruments | | | | | - | | 1,174 | | - | | - | | 1,174 | | Assets of consolidated CLO entity: | | | | | | | | | | | | | | Cash equivalents | | | | | 59,485 | | - | | - | | - | | 59,485 | | Bank loans and other investments | - | | 316,502 | | 2,819 | | - | | 319,321 | | Total financial assets | | | | $ | 247,047 | $ | 572,135 | $ | 2,819 | $ | 237,206 | $ | 1,059,207 |
| Financial liabilities: | | | | | | | | | | | | | | | | Derivative instruments | | $ | - | $ | 6,453 | $ | - | $ | - | $ | 6,453 | | Securities sold, not yet purchased | | - | | 1,603 | | - | | - | | 1,603 | | Liabilities of consolidated CLO entity: | | | | | | | | | | | | | | Senior and subordinated note obligations | - | | 2,667 | | 365,460 | | - | | 368,127 | | Total financial liabilities | | | | $ | - | $ | 10,723 | $ | 365,460 | $ | - | $ | 376,183 |
| October 31, 2012 | | | | | | | | | | | | | | | | (in thousands) | | | | | Level 1 | | Level 2 | | Level 3 | | Other Assets Not Held at Fair Value | | Total | | | | | | | | | | | | | | | | | | | Financial assets: | | | | | | | | | | | | | | | | Cash equivalents | | | | $ | 16,390 | $ | 139,469 | $ | - | $ | - | $ | 155,859 | | Investments: | | | | | | | | | | | | | | | | Investment securities, trading – debt | | 4,512 | | 66,293 | | | - | | - | | 70,805 | | Investment securities, trading – equity | | 87,991 | | 31,457 | | | - | | - | | 119,448 | | Investment securities, available-for-sale | | 26,736 | | 4,412 | | - | | - | | 31,148 | | Investment in non-consolidated CLO | | | | | | | | | | | | | entity(1) | | - | | - | | - | | 350 | | 350 | | Investments in equity method investees(2) | | - | | - | | - | | 257,652 | | 257,652 | | Investments, other(3) | | - | | 60 | | - | | 7,470 | | 7,530 | | Derivative instruments | | | | | - | | 2,229 | | - | | - | | 2,229 | | Assets of consolidated CLO entity: | | | | | | | | | | | | | | Cash equivalents | | | | | 34,561 | | - | | - | | - | | 34,561 | | Bank loans and other investments | 98 | | 428,282 | | 2,203 | | - | | 430,583 | | Total financial assets | | | | $ | 170,288 | $ | 672,202 | $ | 2,203 | $ | 265,472 | $ | 1,110,165 | | | | | | | | | | | | | | | | | | | Financial liabilities: | | | | | | | | | | | | | | | | Derivative instruments | | $ | - | $ | 788 | $ | - | $ | - | $ | 788 | | Securities sold, not yet purchased | | - | | 26,142 | | - | | - | | 26,142 | | Liabilities of consolidated CLO entity: | | | | | | | | | | | | | | Senior and subordinated note obligations | - | | 2,659 | | 443,946 | | - | | 446,605 | | Total financial liabilities | | | | $ | - | $ | 29,589 | $ | 443,946 | $ | - | $ | 473,535 | | (1) | The Company’s investment in this CLO entity is measured at fair value on a non-recurring basis using Level 3 inputs. | | | | The investment is carried at amortized cost unless facts and circumstances indicate that the investment has been | | | | impaired, at which time the investment is written down to fair value. There was no re-measurement of this asset during | | | | the six month period ended April 30, 2013 or the twelve month period ended October 31, 2012. | | | (2) | Investments in equity method investees are not measured at fair value in accordance with GAAP. | | (3) | Investments, other include investments carried at cost that are not measured at fair value in accordance with GAAP. |
|
| Summary of the changes in Level 3 assets and liabilities measured at fair value on a recurring basis |
| | | | | Three Months Ended | | | Three Months Ended | | | | | | April 30, 2013 | | | April 30, 2012 | | (in thousands) | | Bank loans and other investments of consolidated CLO entity | | | Senior and subordinated note obligations of consolidated CLO entity | | | Bank loans and other investments of consolidated CLO entity | | | Senior and subordinated note obligations of consolidated CLO entity | | | | | | | | | | | | | | | | | Beginning balance | $ | 2,658 | | $ | 408,924 | | $ | 4,728 | | $ | 480,345 | | Net gains (losses) on investments and | | | | | | | | | | | | | | note obligations included in net | | | | | | | | | | | | | | income(1) | | 57 | | | 1,671 | | | (9) | | | 5,301 | | Principal paydown | | 0 | | | (45,135) | | | 0 | | | - | | Transfers into Level 3(2) | | 104 | | | - | | | 15 | | | - | | Transfers out of Level 3(3) | | - | | | - | | | (2,584) | | | (2,584) | | Ending balance | $ | 2,819 | | $ | 365,460 | | $ | 2,150 | | $ | 483,062 | | Change in unrealized (losses) gains | | | | | | | | | | | | | included in net income relating to | | | | | | | | | | | | | | assets and liabilities held | $ | 57 | | $ | 1,671 | | $ | (9) | | $ | 5,301 |
| | | | | Six Months Ended | | | Six Months Ended | | | | | | April 30, 2013 | | | April 30, 2012 | | (in thousands) | | Bank loans and other investments of consolidated CLO entity | | | Senior and subordinated note obligations of consolidated CLO entity | | | Bank loans and other investments of consolidated CLO entity | | | Senior and subordinated note obligations of consolidated CLO entity | | | | | | | | | | | | | | | | | Beginning balance | $ | 2,203 | | $ | 443,946 | | $ | 5,910 | | $ | 477,699 | | Net gains (losses) on investments and | | | | | | | | | | | | | | note obligations included in net | | | | | | | | | | | | | | income(1) | | 21 | | | 5,256 | | | (49) | | | 7,947 | | Principal paydown | | 0 | | | (83,742) | | | 0 | | | - | | Transfers into Level 3(2) | | 595 | | | - | | | 15 | | | - | | Transfers out of Level 3(3) | | - | | | - | | | (3,726) | | | (2,584) | | Ending balance | $ | 2,819 | | $ | 365,460 | | $ | 2,150 | | $ | 483,062 | | Change in unrealized (losses) gains | | | | | | | | | | | | | included in net income relating to | | | | | | | | | | | | | | assets and liabilities held | $ | 21 | | $ | 5,256 | | $ | (49) | | $ | 7,947 | | (1) | Substantially all net gains and losses on investments and note obligations attributable to the assets and borrowings of the Company's | | | | consolidated CLO entity are allocated to non-controlling and other beneficial interests on the Company's Consolidated Statements of Income. | | (2) | Transfers into Level 3 were the result of a reduction in the availability of significant observable inputs used in determining the fair value | | | | of a second lien term loan. Fair value was determined utilizing a discounted cash flow analysis. | | (3) | Transfers out of Level 3 into Level 2 were due to an increase in the observability of the inputs used in determining the fair value of certain | | | | instruments. |
|